BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15460484)

  • 1. [Very severe pregnancy hemolysis...].
    Sève P; Ferry T; Vial T; Stankovic K; Bui-Xuan C; Broussolle C
    Rev Med Interne; 2004 Jun; 25 Suppl 2():S290-1. PubMed ID: 15460484
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery.
    Shariatmadar S; Storry JR; Sausais L; Reid ME
    Immunohematology; 2004; 20(1):63-6. PubMed ID: 15373671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery.
    Naylor CS; Steele L; Hsi R; Margolin M; Goldfinger D
    Am J Obstet Gynecol; 2000 Jun; 182(6):1427-8. PubMed ID: 10871459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2003 Nov; 43(11):1640-1. PubMed ID: 14617328
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotetan-induced life-threatening haemolysis.
    Robinson HE; Maxwell EL; Prince HM; O'Reilly MA; Jakobovits A
    Med J Aust; 2006 Mar; 184(5):251. PubMed ID: 16515440
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.
    Garratty G; Leger RM; Arndt PA
    Am J Obstet Gynecol; 1999 Jul; 181(1):103-4. PubMed ID: 10411803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotetan-induced hemolytic anemia after bariatric procedures.
    Allen JW; Acosta J; Casós SR; Baldwin LL; Cacchione RN; Rodriguez JL
    Surg Obes Relat Dis; 2006; 2(3):393-6. PubMed ID: 16925360
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal anaphylactic shock in pregnancy: A case report.
    Jeon HJ; Ryu A; Min J; Kim NS
    Medicine (Baltimore); 2018 Sep; 97(37):e12351. PubMed ID: 30212990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan.
    Ray EK; Warkentin TE; O'Hoski PL; Gregor P
    Can J Surg; 2000 Dec; 43(6):461-2. PubMed ID: 11129837
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefotetan disodium-induced hemolytic anemia.
    Wagner BK; Heaton AH; Flink JR
    Ann Pharmacother; 1992 Feb; 26(2):199-200. PubMed ID: 1554932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced immune hemolytic anemia.
    Garratty G
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotetan-induced hemolytic anemia: a case report and review of the literature.
    Moes GS; MacPherson BR
    Arch Pathol Lab Med; 2000 Sep; 124(9):1344-6. PubMed ID: 10975934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death.
    Sengupta A; Kohli JK
    J Obstet Gynaecol Res; 2008 Apr; 34(2):252-4. PubMed ID: 18412791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More.
    Banoub M; Curless MS; Smith JM; Jarrell AS; Cosgrove SE; Rock C; Avdic E
    Surg Infect (Larchmt); 2018 Jul; 19(5):504-509. PubMed ID: 29717917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotetan and ceftriaxone for single-dose prophylaxis in cesarean section.
    Fedele L; Acaia B; Marchini M; Baglioni A; Frigoli A; De Pascale A
    J Chemother; 1989 Jul; 1(4 Suppl):1042-3. PubMed ID: 16312763
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia.
    Mohammed S; Knoll S; van Amburg A; Mennes PA
    Am J Hematol; 1994 Aug; 46(4):369-70. PubMed ID: 8037194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.